NCT02694965View on ClinicalTrials.gov

Understanding Immunotherapy Resistance Mechanisms in Advanced Melanoma

CompletedOBSERVATIONAL

Enrollment

122

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

June 7, 2023

Study Completion Date

June 7, 2023

Conditions

Melanoma

Interventions

OTHER

observational

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER